[ Price : $8.95]
Former FDA commissioner David Kessler tells a House hearing that recent FDA staff cuts will adversely affect the U.S.s public heal...[ Price : $8.95]
The Minneapolis Star Tribune says medical device companies are concerned that FDA layoffs have resulted in fewer device approvals ...[ Price : $8.95]
FDA regulatory experts warn that the agencys user fee programs could be in jeopardy based on sweeping layoffs and political indiff...[ Price : $8.95]
Physician Douglas Smith petitions FDA to take 11 steps to curtail the use of the indications of opioid addiction and opioid use di...[ Price : $8.95]
ZyVersa Therapeutics says a new regulatory development could significantly shorten the path to approval for treatments targeting f...[ Price : $8.95]
Three former FDAers warn of a slow-moving catastrophe coming for the agency as it loses staff and resources under leaders who have...[ Price : $8.95]
FDA approves Bristol Myers Squibbs combination of Opdivo (nivolumab) with Yervoy (ipilimumab) for treating certain adult and pedia...[ Price : $8.95]
FDA warns Lawrenceville, NJ-based EpiCare Acquisitions about Quality System and other violations in its manufacturing of a family ...